Refocusing the AIM on HDL in the metabolic syndrome.
Publication
, Journal Article
McGarrah, RW
Published in: Atherosclerosis
August 2016
Duke Scholars
Published In
Atherosclerosis
DOI
EISSN
1879-1484
Publication Date
August 2016
Volume
251
Start / End Page
531 / 533
Location
Ireland
Related Subject Headings
- Triglycerides
- Metabolic Syndrome
- Lipoproteins, HDL
- Humans
- Cholesterol, HDL
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
McGarrah, R. W. (2016). Refocusing the AIM on HDL in the metabolic syndrome. Atherosclerosis, 251, 531–533. https://doi.org/10.1016/j.atherosclerosis.2016.06.051
McGarrah, Robert W. “Refocusing the AIM on HDL in the metabolic syndrome.” Atherosclerosis 251 (August 2016): 531–33. https://doi.org/10.1016/j.atherosclerosis.2016.06.051.
McGarrah RW. Refocusing the AIM on HDL in the metabolic syndrome. Atherosclerosis. 2016 Aug;251:531–3.
McGarrah, Robert W. “Refocusing the AIM on HDL in the metabolic syndrome.” Atherosclerosis, vol. 251, Aug. 2016, pp. 531–33. Pubmed, doi:10.1016/j.atherosclerosis.2016.06.051.
McGarrah RW. Refocusing the AIM on HDL in the metabolic syndrome. Atherosclerosis. 2016 Aug;251:531–533.
Published In
Atherosclerosis
DOI
EISSN
1879-1484
Publication Date
August 2016
Volume
251
Start / End Page
531 / 533
Location
Ireland
Related Subject Headings
- Triglycerides
- Metabolic Syndrome
- Lipoproteins, HDL
- Humans
- Cholesterol, HDL
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology